healthcare professionals

Navamedic Q3 2021 Results Presentation, Nov 4th

Link to webcast
CEO update

“We work systematically to strengthen our core business by delivering growth through the introduction of new products in existing markets and expanding products to new geographies. We have started and will continue the tedious process to increase company value by owning new products and brands. As a third step, we have been and will actively continue to source and evaluate M&A opportunities to deliver sustainable growth with the objective of building Navamedic to a leading Nordic pharmaceutical company with a footprint in North Europe and other selected countries,” says Kathrine Gamborg Andreassen, CEO of Navamedic ASA.

CEO update
Meet us at exhibitions and fairs
Text
Country
Date
Text
Country
Date
The Finnish Metabolic Club
Finland
November 25-26
The Finnish Metabolic Club
Finland
November 25-26
Diabetesforum
Sweden
December 1-3
Diabetesforum
Sweden
December 1-3
Obesitasdagen
Sweden
December 10
Obesitasdagen
Sweden
December 10
DUGS
Denmark
January 7
DUGS
Denmark
January 7
DDS
Denmark
January 19-21
DDS
Denmark
January 19-21